Approved for MIMRYLO is indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV).. Rusfertide is a mimetic of the endogenous hormone hepcidin that blocks the iron transporter ferroportin. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…